[
    {
        "ID": "4",
        "Name": "AC Immune SA",
        "Articles": [
            {
                "Description": "COVID-19 Update: Global Alpha Synuclein Market is Expected to Grow at a Healthy CAGR with Top players: AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, etc. | InForGrowth  Jewish Life News",
                "Date": "15 Jun 2020 16:02:13",
                "Title": "COVID-19 Update: Global Alpha Synuclein Market is Expected to Grow at a Healthy CAGR with Top players: AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, etc. | InForGrowth - Jewish Life News",
                "Url": "https://jewishlifenews.com/market-report/covid-19-update-global-alpha-synuclein-market-is-expected-to-grow-at-a-healthy-cagr-with-top-players-ac-immune-sa-affiris-ag-bioarctic-ab-biogen-inc-evotec-ag-etc-inforgrowth/"
            }
        ]
    },
    {
        "ID": "11",
        "Name": "Achaogen, Inc.",
        "Articles": [
            {
                "Description": "Global Pyelonephritis Drug Market Analysis 2020 with COVID-19 | Growth, Trend, Competitive Strategies and Forecast 2025  Jewish Life News",
                "Date": "17 Jun 2020 04:57:00",
                "Title": "Global Pyelonephritis Drug Market Analysis 2020 with COVID-19 | Growth, Trend, Competitive Strategies and Forecast 2025 - Jewish Life News",
                "Url": "https://jewishlifenews.com/industry-analysis/global-pyelonephritis-drug-market-analysis-2020-with-covid-19-growth-trend-competitive-strategies-and-forecast-2025/"
            }
        ]
    },
    {
        "ID": "16",
        "Name": "Adamis Pharmaceuticals Corporation",
        "Articles": [
            {
                "Description": "Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19  GlobeNewswireAdamis Pharmaceuticals (ADMP) Announces License to Commercialize Tempol for Treatment of Respiratory Diseases Including COVID-19  StreetInsider.comAre Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Prospects Worsening?  statereviewer.comMay Prove More Resilient Than The Market Believes: Aflac Incorporated (AFL) and Adamis Pharmaceuticals Corporation (ADMP)  BOV NewsView Full Coverage on Google News",
                "Date": "15 Jun 2020 13:06:13",
                "Title": "Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19 - GlobeNewswire",
                "Url": "https://www.globenewswire.com/news-release/2020/06/15/2048114/0/en/Adamis-Pharmaceuticals-Announces-License-to-Commercialize-Tempol-a-Novel-Investigational-Anti-inflammatory-and-Antioxidant-Drug-for-the-Treatment-of-Respiratory-Diseases-Including-.html"
            }
        ]
    },
    {
        "ID": "45",
        "Name": "Alder BioPharmaceuticals, Inc.",
        "Articles": [
            {
                "Description": "GLOBAL MIGRAINE TREATMENT MARKET (COVID 19 Impact Analysis) Data Highlighting Major Vendors, Promising Regions, Anticipated Growth Forecast To 2027  Jewish Life News",
                "Date": "16 Jun 2020 14:46:05",
                "Title": "GLOBAL MIGRAINE TREATMENT MARKET (COVID 19 Impact Analysis) Data Highlighting Major Vendors, Promising Regions, Anticipated Growth Forecast To 2027 - Jewish Life News",
                "Url": "https://jewishlifenews.com/uncategorized/global-migraine-treatment-market-covid-19-impact-analysis-data-highlighting-major-vendors-promising-regions-anticipated-growth-forecast-to-2027/"
            }
        ]
    }
]